Spots Global Cancer Trial Database for androgen receptor targeted therapy
Every month we try and update this database with for androgen receptor targeted therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate Cancer | NCT03150056 | Solid Tumours | GSK525762 Abiraterone Enzalutamide Prednisone | 18 Years - | GlaxoSmithKline |